Skip to Content

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR)

Securities Class Action

  • Date:
  • 2/13/2020
  • Company Name:
  • Arrowhead Pharmaceuticals, Inc.
  • Stock Symbol:
  • ARWR
  • Status:
  • Investigating

Case Finder

Locate any case using the tools below.

NEW YORK, March 18, 2020 –Bragar Eagel & Squire is investigating certain officers and directors of Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) for potential breach of fiduciary duty.

If you are a long-term stockholder of Arrowhead securities, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Melissa Fortunato or Marion Passmore by email at investigations@bespc.com, telephone at (212) 355-4648, or by filling out the form below.  There is no cost or obligation to you.
The individual or institution below (“Plaintiff”) has reviewed and agrees to the Bragar Eagel & Squire, P.C. (“BESPC”) retainer agreement and authorizes BESPC to prosecute an action on Plaintiff’s behalf under the federal securities laws or applicable state laws to recover damages on behalf of investors in Arrowhead Pharmaceuticals. BESPC will prosecute the action on a full contingency basis and will forward all costs and expenses.
 

Case Finder

Locate any case using the tools below.

You may share a link to this page on any of the sites listed below or send link via email: